Iyer A, Hennessey D, O’Keefe S, Patterson J, Wang W, Wong G K-S, Gniadecki R. Skin colonization by circulating neoplastic clones in cutaneous T-cell lymphoma. Blood. 2019; in press
Proposal for a new model of the pathogenesis of cutaneous lymphomas
Kamstrup MR, Gjerdrum LMR, Biskup E, Lauenborg BT, Ralfkiaer E, Woetmann A, Ødum N, Gniadecki R. Notch1 as a potential therapeutic target in cutaneous T-cell lymphoma. Blood. 2010;116: 2504–2512.
Discovery of Notch1 as a potential therapeutic target in cutaneous lymphomas
Kamstrup MR, Specht L, Skovgaard GL, Gniadecki R. A prospective, open-label study of low-dose total skin electron beam therapy in mycosis fungoides. Int J Radiat Oncol Biol Phys. 2008;71: 1204–1207.
First clinical trial showing the efficacy of low-dose electron beam radiation in mycosis fungoides
Mourad A, Straube S, Armijo-Olivo S, Gniadecki R. Factors predicting persistence of biologic drugs in psoriasis: a systematic review and meta-analysis. Br J Dermatol. 2019;181: 450–458.
Methodology of metaanalysis of the real-world data
Gniadecki R, Bang B, Bryld LE, Iversen L, Lasthein S, Skov L. Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris. Br J Dermatol. 2015;172: 244–252
Proposal of the drug survival as the endpoint for real-world analysis of treatment efficiency. This paper is one of the most higly cited in Br J Dermatol (>150 citations).